1-12 of 12
Andrés J.M. Ferreri, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Activity and Safety of RP6530, a Dual PI3Kδ/γ Inhibitor, in Patients with Advanced Hematologic Malignancies: Final Analysis of a Phase 1 Multicenter Study

Carmelo Carlo-Stella, MD, Richard Delarue, MD, Prajak J Barde, MD, Lydia Scarfo, Uday Kumar, Srikant Viswanadha, PhD, Silvia Laura Locatelli, PhD, Sara Gandolfi, MD, Valeria Pittari, MD, Lucia Morello, Massimo Magagnoli, Armando Santoro, Andrés J.M. Ferreri, MD
Journal: Blood
Blood (2016) 128 (22): 3011.
https://doi.org/10.1182/blood.V128.22.3011.3011
Published: 2016
Journal Articles

Rituximab Plus Lenalidomide Versus Rituximab Monotherapy in Untreated Follicular Lymphoma Patients in Need of Therapy. First Analysis of Survival Endpoints of the Randomized Phase-2 Trial SAKK 35/10

Eva Kimby, MD professor, Stephanie Rondeau, MSc, Anna Vanazzi, MD, Bjorn Ostenstad, MD PhD, Ulrich J.M. Mey, MD, Daniel Rauch, MD, Björn E Wahlin, MD PhD, Felicitas Hitz, MD, Micaela Hernberg, MD, Ann-Sofie Johansson, MD, Peter de Nully Brown, MD PhD, Hans Hagberg, MD PhD, Andres J.M. Ferreri, MD professor, Andreas Lohri, MD professor, Urban Novak, MD, Thilo Zander, MD, Hanne Bersvendsen, MD, Mario Bergetzi, MD, Walter Mingrone, MD, Fatime Krasniqi, MD PhD, Stefan Dirnhofer, MD professor, Hanne Hawle, MD, Simona Berardi, PhD, Michele Ghielmini, MD professor, Emanuele Zucca
Journal: Blood
Blood (2016) 128 (22): 1099.
https://doi.org/10.1182/blood.V128.22.1099.1099
Published: 2016
Journal Articles

Effects on Survival and Neurocognitive Functions of Whole-Brain Radiotherapy (WBRT) and Autologous Stem Cell Transplantation (ASCT) as Consolidation Options after High-Dose Methotrexate-Based Chemoimmunotherapy in Patients with Newly Diagnosed Primary CNS Lymphoma (PCNSL): Results of the Second Randomization of the IELSG32 Trial

Andrés J.M. Ferreri, MD, Kate Cwynarski, MBBS, FRPATH, PhD, Elisa Jacobsen Pulczynski, MD, Christopher P. Fox, MBChB, PhD, Elisabeth Schorb, MD, Paul La Rosée, MD, Mascha Binder, MD, Alberto Fabbri, MD, Valter Torri, MD, Eleonora Minacapelli, MD, Monica Falautano, MD, Fiorella Ilariucci, MD, Achille Ambrosetti, MD, Alexander Röth, MD, Claire Jane Hemmaway, MD, Peter M Johnson, MA, MD, Kim Linton, MBChB, MRCP, PhD, Tobias Pukrop, MD, Jette Sonderskov Gorlov, MD, Monica Balzarotti, MD, Georg Hess, MD, Ulrich Keller, MD, Stephan Stilgenbauer, MD, Jens P. Panse, MD, Alessandra Tucci, MD, Lorella Orsucci, MD, Francesco Pisani, MD, Alessandro Levis, MD, Stefan W. Krause, MD, Hans-Joachim Schmoll, MD PhD, Bernd Hertenstein, MD, Mathias Rummel, MD PhD, Jeffery Smith, MD, Michael Pfreundschuh, MD, PhD, Giuseppina Cabras, MD, Francesco Angrilli, MD, Maurilio Ponzoni, MD, Martina Deckert, MD, Letterio S. Politi, MD, Jurgen Finke, MD, Michele Reni, MD, Franco Cavalli, Emanuele Zucca, Gerald Illerhaus, MD
Journal: Blood
Blood (2016) 128 (22): 511.
https://doi.org/10.1182/blood.V128.22.511.511
Published: 2016
Journal Articles

Lenalidomide Maintenance Significantly Improves Survival Figures in Patients with Relapsed Diffuse Large B-Cell Lymphoma (rDLBCL) Who Are Not Eligible for Autologous Stem Cell Transplantation (ASCT): Final Results of a Multicentre Phase II Trial

Andrés J.M. Ferreri, MD, Marianna Sassone, MD, Francesco Zaja, MD, Alessandro Re, MD, Michele Spina, Alice Di Rocco, MD, Alberto Fabbri, MD, Caterina Stelitano, MD, Maurizio Frezzato, MD, Chiara Rusconi, MD, Renato Zambello, MD, Suzana Couto, MD, Yan Ren, MD, Annalisa Arcari, Giovanni Bertoldero, MD, Lucilla Tedeschi, MD, Francesca Re, MD, Lydia Scarfo, Teresa Calimeri, MD PhD, Caterina Cecchetti, MD, Marianna Chiozzotto, MD, Silvia Govi, MD, Maurilio Ponzoni, MD
Journal: Blood
Blood (2016) 128 (22): 474.
https://doi.org/10.1182/blood.V128.22.474.474
Published: 2016
Journal Articles

A Phase I Dose Escalation Study of RP6530, a Novel, Dual PI3K-γδ Inhibitor, for Patients with Relapsed or Refractory Hematologic Malignancies

Lydia Scarfò, Prajak J Barde, MBBS, MD, Claudia Fazi, PhD, Uday Kumar, Srikant Viswanadha, PhD, Swaroop Vakkalanka, PhD, Paolo Ghia, MD, Andres J.M. Ferreri, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3043.
https://doi.org/10.1182/blood.V124.21.3043.3043
Published: 2014
Journal Articles

NF-κB Subunit c-Rel Cooperates with Myc and Mutated p53 to Confer Significantly Worse Survival in Patients with Diffuse Large B-Cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program

Ling Li, MD, Zijun Yidan Xu-Monette, PhD, Chi Young Ok, MD, Alexander Tzanko, Carlo Visco, Nora Gisin, Santiago Montes-Moreno, MD PhD, Karen Dybkær, April Chiu, MD, Attilio Orazi, MD, Youli Zu, MD PhD, Govind Bhagat, MD, Kristy L. Richards, MDPhD, Eric D. Hsi, MD, William W. L. Choi, MD PhD, Joannes H.J.M. Van Krieken, PhDMD, Jooryung Huh, Maurilio Ponzoni, Andres J.M. Ferreri, MD PhD, Michael B. Møller, MD DMSc, Ronald S. Go, MD, Jane N. Winter, MD, Miguel A. Piris, MD PhD, L. Jeffrey Medeiros, MD, Ken H. Young, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1620.
https://doi.org/10.1182/blood.V124.21.1620.1620
Published: 2014
Journal Articles

Akt Activation Confers an Inferior Survival in Patients with Activated B-Cell Subtype of Diffuse Large B-Cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program

Qi Shen, Zijun Yidan Xu-Monette, PhD, Ganiraju Manyam, Carlo Visco, Alexander Tzankov, MD PhD, Xin Cao, Lijuan Deng, Santiago Montes-Moreno, MD PhD, Karen Dybkær, April Chiu, MD, Attilio Orazi, MD, Youli Zu, MD PhD, Govind Bhagat, MD, Kristy L. Richards, MDPhD, Eric D. Hsi, MD, William Choi, Joannes H.J.M. Van Krieken, PhDMD, Jooryung Huh, Maurilio Ponzoni, MD, Andres J.M. Ferreri, MD PhD, John P. Farnen, MD, Michael B. Møller, MD DMSc, Jane N. Winter, MD, Miguel Angel A. Piris, MD PhD, L. Jeffrey Medeiros, MD, Ken H. Young, MD PhD
Journal: Blood
Blood (2014) 124 (21): 143.
https://doi.org/10.1182/blood.V124.21.143.143
Published: 2014
Journal Articles

Interim Analysis Of An Ongoing PHASE II Trial Assessing Safety and Efficacy Of Lenalidomide Maintenance In Patients With Chemosensitive Relapse Of Diffuse Large B-CELL Lymphoma (DLBCL)

Silvia Govi, MD, Marta Bruno Ventre, MD, Francesco Zaja, Alice Di Rocco, MD, Michele Spina, Daniele Vallisa, MD, Lydia Scarfo', MD, Marianna Chiozzotto, MD, Rosanna Cuccurullo, MD, Angelo Fama, MD, Andrés J.M. Ferreri, MD
Journal: Blood
Blood (2013) 122 (21): 3055.
https://doi.org/10.1182/blood.V122.21.3055.3055
Published: 2013
Journal Articles

Risk-Tailored CNS Prophylaxis In 194 Patients With Diffuse Large B-CELL Lymphoma (DLBCL) Treated In The Rituximab ERA: Risk Definition By Clinical Variables and Ontogenic Stratification

Marta Bruno Ventre, MD, Marco Foppoli, MD, Giovanni Citterio, MD, Giovanni Donadoni, MD, Maurilio Ponzoni, MD, Silvia Govi, MD, Lydia Scarfò, MD, Marianna Sassone, MD, Federico Caligaris -Cappio, MD, Prof., Andres J.M. Ferreri, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4365.
https://doi.org/10.1182/blood.V122.21.4365.4365
Published: 2013
Journal Articles

STAT3 Expression and Clinical Implications In De Novo Diffuse Large B-Cell Lymphoma: A Report From The International DLBCL Rituximab-CHOP Consortium Program

Chi Young Ok, MD, Zijun Y. Xu-Monette, PhD, Alexander Tzankov, MD, PhD, Carlo Visco, MD, Santiago M. Montes, MD, PhD, Karen Dybkaer, PhD, April Chiu, MD, Attilio Orazi, MD, Youli Zu, MD, PhD, Govind Bhagat, MD, PhD, Kristy L. Richards, MD PhD, Eric D. Hsi, MD, William W. L. Choi, MD, PhD, Joannes H.J.M. Van Krieken, PhD, MD, Qin Huang, MD, PhD, Jooryung Huh, MD, Weiyun Z. Ai, MD, PhD, Maurilio Ponzoni, MD, AndrÉs J.M. Ferreri,, MD, PhD, John P. Farnen, MD, FACP, Michael B. Moller, MD, PhD, Jane N. Winter, MD, Miguel A. Piris, MD, PhD, L. Jeffrey Medeiros, MD, Ken H. Young, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 365.
https://doi.org/10.1182/blood.V122.21.365.365
Published: 2013
Journal Articles

MYC Mutation Profiling In 708 De Novo Diffuse Large B-Cell Lymphoma Demonstrates That Genetic Abnormalities In The Coding Sequence and Untranslated Regions Have Different Prognostic and Clinical Significance: A Report From The International DLBCL Rituximab-CHOP Consortium Program

Zijun Y. Xu-Monette, PhD, Alexander Tzankov, MD, Yong Li, PhD, Carlo Visco, MD, Santiago Montes-Moreno, MD, PhD, Karen Dybkaer, PhD, April Chiu, MD, Attilio Orazi, MD, Youli Zu, MD, PhD, Govind Bhagat, MD, Kristy L. Richards, MD PhD, Eric D. Hsi, MD, William W. L. Choi, MD, PhD, Joannes H.J.M. Van Krieken, PhD, MD, Jooryung Huh, MD, Weiyun Z. Ai, MD, PhD, Maurilio Ponzoni, MD, Andres J.M. Ferreri, MD, PhD, John P. Farnen, MD, FACP, Michael B. Moller, MD, PhD, Jane N. Winter, MD, Miguel A. Piris, MD, PhD, L. Jeffrey Medeiros, MD, Ken H. Young, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 363.
https://doi.org/10.1182/blood.V122.21.363.363
Published: 2013
Journal Articles

The t(14;18)(q32;q21) Characterizes a Subset of Patients with Diffuse Large-B Cell Lymphoma of Germinal Center Origin with Poor Outcome: Report From the International DLBCL Rituximab-CHOP Consortium Program Study

Carlo Visco, MD, Alexander Tzankov, MD, Zijun Y. Xu-Monette, PhD, Roberto N. Miranda, MD, Emanuele S. G. d'Amore, MD, Santiago Montes-Moreno, MD, Karen Dybkaer, PhD, April Chiu, MD, Wayne Tam, MD, PhD, Attilio Orazi, MD, Youli Zu, MD, PhD, Govind Bhagat, MD, Brad S. Kahl, MD, Jane N. Winter, MD, Huan-You Wang, MD, PhD, Cherie H. Dunphy, MD, Eric D. Hsi, MD, Frank X. Zhao, MD, PhD, Ronald S. Go, MD, William W. L. Choi, MD, Fan Zhou, MD, PhD, Magdalena Czader, MD, PhD, Xiaoying Zhao, MD, Joannes H.J.M. Van Krieken, PhD, MD, Qin Huang, MD, PhD, Weiyun Ai, MD, PhD, Joan E. Etzell, MD, Maurilio Ponzoni, MD, Andres J.M. Ferreri, MD, Miguel A. Piris, MD, Michael B. Møller, MD, PhD, Carlos E. Bueso-Ramos, MD, PhD, L. Jeffrey Medeiros, MD, Ken H. Young, MD
Journal: Blood
Blood (2011) 118 (21): 949.
https://doi.org/10.1182/blood.V118.21.949.949
Published: 2011